<DOC>
	<DOCNO>NCT01781663</DOCNO>
	<brief_summary>The main purpose study demonstrate safety efficacy KAM2904 Face Cream KAM3008 Body Lotion reduce symptom mild moderate AD . Efficacy evaluate compare SCORAD Eczema Area Severity Index ( EASI ) group subject treat KAM2904 Face Cream KAM3008 Body Lotion ( treatment group ) , versus group subject treat petrolatum-based moisturizer ( control group ) . Safety determine number severity Adverse Events Device-Related .</brief_summary>
	<brief_title>Efficacy KAM2904 Face Cream KAM3008 Body Lotion Treatment Children With Atopic Dermatitis ( AD )</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Petrolatum</mesh_term>
	<criteria>• Male female 2 12 year age The subject suffers moderate atopic dermatitis ( SCORAD &lt; 40 ) amenable treatment Diagnosis atopic dermatitis meet Hanifin 's criterion ( least 3 basic feature least 3 minor feature ) Atopic dermatitis , opinion investigator , stable past 7 day The subject 's parent able apply study product twice day ( morning evening ) consecutive period 42 day The subject 's parent agree subject change his/her lifestyle study period ( include : regular body hygiene product ( soap ) , number baths shower per day , laundry detergent fabric softener use wash clothes ) The subject 's parent agree use test product study period The subject 's legal guardian able willing sign inform consent form comply study regulation protocol • The subject another dermatological disease/condition could interfere clinical evaluation , include infect atopic dermatitis lesions The subject previous history allergy cosmetic product ingredient include tested formulation ( Appendices 1 2 ) The subject receive topical systemic immunemodulator ( calcineurin inhibitor corticosteroid ) treatment atopic dermatitis , within 14 day prior day 0 The subject underwent phototherapy within 28 day prior day 0 The subject expect extensively expose sun trial The subject underwent experimental treatment within 14 day prior day 0</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>